Document is current
Any future updates will be listed below
-
Authors
Gohari, Sepehr
Reshadmanesh, Tara
Khodabandehloo, Hadi
Fathi, Mojtaba
Ahangar, Hassan http://orcid.org/0000-0001-8183-1188
Arsang-Jang, Shahram
Ismail-Beigi, Faramarz
Ghanbari, Samin
Dadashi, Mohsen
Muhammadi, Muhammad Javad
Gohari, Sheida
Ghaffari, Saeid
-
Funding
Funding for this research was provided by:
Zanjan University of Medical Sciences (1602001000)
DR. ABIDI PHARMACEUTICALS
- License Information
-
More Information
Article History
Received: 21 December 2020
Accepted: 17 June 2021
First Online: 30 June 2021
Declarations
:
: The EMPA-CARD trial is conducting in accordance with the principles of the declaration of Helsinki and all subsequent revisions. The study was approved by the ethics committee of Zanjan university of Medical Sciences. All patients provided with written informed consent prior to the recruitment. Moreover, the study protocol was prospectively registered on the Iranian Registry of Clinical Trials (ExternalRef removed, Identifier: IRCT20190412043247N2).
: Not applicable.
: The authors contributing to the study have nothing relevant to disclose. Only the study authors are responsible for conducting and reporting the final contents of the trial. This study has received a non-financial funding from the Dr. Abidi Pharmaceutical Company.
